Bristol-Myers Squibb Co. (NYSE: BMY) received FDA approval for their melanoma cancer treatment ipilimumab, branded Yervoy, on Friday.
This article: 171 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE